Pharmaceuticals discovered with AI
EFFICIENT DRUG DISCOVERY & DEVELOPMENT
twoXAR Pharmaceuticals is a drug discovery and development company focused on first-in-class small molecules. The company currently has a development portfolio of over 18 diseases. twoXAR saves years in drug development while generating a 30x hit rate at in vivo efficacy milestones over traditional methods.
twoXAR Pharmaceuticals
Drug Discovery and Development Overview
May 2020
LATEST NEWS
LATEST EVENTS
Level Up: Leveraging AI for Drug Discovery as a Biology Startup
Johnson & Johnson Innovaion | JLabs Panel (Digital)
October 1, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin presents and joins the JLabs Panel to discuss how biology startups can partner with AI companies.
The Moneyball Medicine Podcast
September 14, 2020
twoXAR Pharmaceuticals SVP of R&D Mark Eller, Ph.D. joins host Harry Glorikian to discuss his journey from traditional pharma to believing in the power of AI.
The Moneyball Medicine Podcast
August 31, 2020
twoXAR Pharmaceuticals CEO Andrew A. Radin joins host Harry Glorikian to discuss the latest updates from twoXAR Pharmaceuticals.
© 2020 twoXAR, Incorporated | All Rights Reserved